Maternal serum and amniotic fluid hydroxyproline levels in neural tube defects

Fetal Diagnosis and Therapy

Volumn 18, Issue 5, 2003, Pages 321-323

  Özyurt, Hüseyin ^a,e   Totan, Aylin ^b   Şahin, Şemsettin ^c   Kilinç, Cumhur ^d   Söǧüt, Sadik ^a   Akyol, Ömer ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Etlik Education and Research Hospital   (Turkey)

^c Diyarbakir Devlet Hastanesi   (Turkey)

^d Kecioren Hospital Ankara   (Turkey)

^e INONU UNIVERSITY   (Turkey)

Author keywords

Amniotic fluid; Maternal serum; Neural tube defects; OH proline

Indexed keywords

HYDROXYPROLINE;

AMNION FLUID; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FEMALE; FETUS; FOLLOW UP; HUMAN; MATERNAL SERUM; MEDICAL RESEARCH; NEURAL TUBE DEFECT; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

AMNIOTIC FLUID; BIOLOGICAL MARKERS; COLLAGEN; FEMALE; FETAL DISEASES; HUMANS; HYDROXYPROLINE; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 0041660697     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071973     Document Type: Article

References (19)

1. Guvenc H, Karatas F, Guvenc M, Kunc S, Aygun AD, Bektas S: Low levels of selenium in mothers and their newborns in pregnancies with a neural tube defect. Pediatrics 1995;95:879-882.
2. Dreosti IE: Zinc in brain development and function. Prog Clin Biol Res 1993;380:81-90.
3. Hinks LJ, Ogilvy-Stuart A, Hambidge KM, Walker V: Maternal zinc and selenium status in pregnancies with a neural tube defect or elevated plasma alpha-fetoprotein. Br J Obstet Gynaecol 1989;96:61-66.
4. 12 and anencephaly. Lancet 1980;i:880.
5. Berry RJ, Li Z, Erickson JD, et al: Preventing neural tube defects with folic acid in China. N Engl J Med 1999;341:1485-1490.
6. Lucock M, Daskalakis I, Hinkins M, Yates Z: An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol Genet Metab 2001;73:322-332.
7. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P: Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp 1994;181:180-187; discussion 187-191.
8. Melse-Boonstra A, de Bree A, Verhoef P, Bjorke-Monsen AL, Verschuren WM: Dietary monoglutamate and polyglutamate folate are associated with plasma folate concentrations in Dutch men and women aged 20-65 years. J Nutr 2002;132:1307-1312.
9. Melse-Boonstra A, Verhoef P, Konings EJ et al: Influence of processing on total monoglutamate and polyglutamate folate contents of leeks, cauliflower, and green beans. J Agric Food Chem 2002;50:3473-3478.
10. Fowler B: The folate cycle and disease in humans. Kidney Int Suppl 2001;78:S221-S229.
11. Matthews LM, Johnson EM, Newman LM: Introduction of late gestational teratogenesis in rat lung by hypervitaminosis A. Teratology 1981;23:253-258.
12. Graf WD, Oleinik OE, Pippenger CE, Eder DN, Glauser TA, Shurtleff DB: Comparison of erythrocyte antioxidant enzyme activities and embryologic level of neural tube defects. Eur J Pediatr Surg 1995;5(suppl 1):8-11.
13. Graf WD, Pippenger CE, Shurtleff DB: Erythrocyte antioxidant enzyme activities in children with myelomeningocele. Dev Med Child Neurol 1995;37:900-905.
14. Woessner JB: The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophysics 1961;93:440-447.
15. Park CH, Stewart W, Khoury MJ, et al: Is there etiologic heterogeneity between upper and lower neural tube defects? Am J Epidemiol 1992;136:1493-1501.
16. Marks JD, Khoshnood B: Epidemiology of common neurosurgical disease in the neonate. Neurosurg Clin North Am 1998;9:63-72.
17. Principles of Biochemistry. The three-dimensional structure of proteins; Lehninger AL, Nelson DL, Cox MM (eds): New York, Worth Publishers, 1993, pp 160-197.
18. Mills JL, Mcpartlin JM, Kirke PN et al: Homocystein metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-151.
19. Steegers-Theunissen RP, Boers GH, Blom HJ, et al: Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 1995;172:1436-1441.